Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K4 | O95819 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 3/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 2/20 | 0.37 |
| ▸ | ICMT | O60725 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.36 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.34 |
| ▸ | PLAU | P00749 | 1/20 | 0.34 |
| ▸ | SCN7A | Q01118 | 1/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28913586 | 0.94 | GABRA1 (0.40) | MAP4K4CYP11B1CYP11B2 | |
| SCHEMBL21116882 | 0.93 | RORC (0.40) | MAP4K4KIF11PGR | |
| SCHEMBL21116481 | 0.92 | CYP11B1 (0.35) | MAP4K4KIF11MMP3PGRESR1 | |
| SCHEMBL21116856 | 0.89 | CYP11B1 (0.36) | MAP4K4PGRESR1ESR2CYP11B1 | |
| SCHEMBL30311704 | 0.88 | CYP11B1 (0.39) | CYP11B1CYP11B2 | |
| SCHEMBL28424749 | 0.88 | CYP11B1 (0.39) | CYP11B1CYP11B2 | |
| SCHEMBL21116902 | 0.88 | CYP11B1 (0.42) | CYP11B1CYP11B2 | |
| SCHEMBL21116512 | 0.88 | CHEK1 (0.40) | MAP4K4KIF11MMP3PGRESR1 | |
| SCHEMBL21116251 | 0.87 | STS (0.41) | MAP4K4CYP11B1CYP11B2 | |
| SCHEMBL17935058 | 0.87 | ALDH1A1 (0.36) | PGRCYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, NOX3, ORC3 | MAP4K4 3577/4885KIF11 3544/4885MMP3 1303/4885 |
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | OR10J3, ORC3, NOX3 | MAP4K4 3805/4885KIF11 3520/4885MMP3 1222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.